| A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence | |
| Tefferi A; Al-Ali H K; Barosi G; Devos T; Gisslinger H; Jiang Q; Kiladjian J-J; Mesa R; Passamonti F; McMullin M F | |
| 2017 | |
| 卷号 | 31期号:4页码:896-902 |
| ISSN号 | 1476-5551 |
| DOI | 10.1038/leu.2016.300 |
| URL标识 | 查看原文 |
| 收录类别 | PUBMED |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6367365 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Tefferi A,Al-Ali H K,Barosi G,et al. A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence[J],2017,31(4):896-902. |
| APA | Tefferi A.,Al-Ali H K.,Barosi G.,Devos T.,Gisslinger H.,...&Gale R P.(2017).A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence.,31(4),896-902. |
| MLA | Tefferi A,et al."A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence".31.4(2017):896-902. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论